Rwanda vs Togo: Cause of death, by non-communicable diseases, ages 15-59, female
Rwanda
51.7%
in 2021
Togo
52.0%
in 2021
Rwanda rank
128th
Togo rank
125th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Rwanda
- Togo
How they compare
Togo currently reports 52.0% against 51.7% in Rwanda, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Togo ahead.
Rwanda ranks 128th and Togo ranks 125th of 185 countries.
Across the 3 decades both report, Rwanda averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Rwanda | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.3% | 32.9% | 6.5% | Togo |
| 2010s | 46.7% | 44.2% | 2.5% | Rwanda |
| 2020s | 52.3% | 52.0% | 0.2% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Rwanda or Togo?
- Togo, at 52.0% against 51.7% in Rwanda as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Rwanda and Togo?
- 0.3%, with Togo ahead.
- How many years of comparable data are there for Rwanda and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Rwanda and Togo rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Rwanda ranks 128th and Togo ranks 125th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.